メインコンテンツに移動

Linking to longevity

The low correlation between mortality and returns on most asset classes means that US-traded life settlement policies are a marketable underlying. But while trading longevity risk is set to rise among institutions, some structured products providers are unwilling to offer mortality-linked investments to retail investors. By Amanda Lee

A report by US investment research firm Bernstein Research predicts that the life settlement market in the US (see box page 26) could grow from $13 billion as of 2004 to $160 billion by 2030, possibly even sooner. The report also estimates that life settlements can provide an internal rate of return of between 9% and 13%.

For financial institutions, including structured products providers, the fact

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here